Effects of dopaminergic drugs on the mast cell degranulation and nitric oxide generation in RAW 264.7 cells

Archives of Pharmacal Research

Volumn 27, Issue 1, 2004, Pages 94-98

  Seol, Il Woong ^a   Na, Youn Kuo ^a   Kim, Kyeong Man ^a  

^a Chonnam National University   (South Korea)

Author keywords

Degranulation; Dopaminergic drugs; Macrophage; Mast cell; Nitric oxide

Indexed keywords

7 HYDROXY 2 N,N DIPROPYLAMINOTETRALIN; 7-HYDROXY-2-N,N-DIPROPYLAMINOTETRALIN; BETA N ACETYLHEXOSAMINIDASE; BROMOCRIPTINE; CLOZAPINE; DIAGNOSTIC AGENT; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; ENZYME PRECURSOR; HALOPERIDOL; IMMUNOGLOBULIN E RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; NOS2 PROTEIN, MOUSE; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; QUERCETIN; SIGNAL PEPTIDE; TETRALIN DERIVATIVE;

ANIMAL; ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; CYTOLOGY; DEGRANULATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; GENETICS; MAST CELL; METABOLISM; METHODOLOGY; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASE; BROMOCRIPTINE; CELL DEGRANULATION; CELL LINE, TUMOR; CLOZAPINE; DOPAMINE; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ENZYME PRECURSORS; HALOPERIDOL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; MAST CELLS; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PROTEIN-TYROSINE KINASES; QUERCETIN; RECEPTORS, IGE; SIGNAL TRANSDUCTION; TETRAHYDRONAPHTHALENES;

EID: 6944223158     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02980053     Document Type: Article

References (13)

1. Carr, L., Tucker, A., and Fernandez-Botran, R., In vivo administration of L-dopa or dopamine decreases the number of splenic IFNgamma-producing cells. J. Neuroimmunol., 137, 87-93 (2003).
2. Filipov, N. M., Cao, L., Seegal, R. F., and Lawrence, D. A., Compromised peripheral immunity of mice injected intrastriatally with six-hydroxydopamine. J. Neuroimmunol., 132,129-139 (2002).
3. Fischer, B. and Schmutzler, W., Inhibition by azelastine of the immunologically induced histamine release from isolated guinea pig mast cells. Arzneimittelforschung, 31, 1193-1195 (1981).
4. Hunot, S., Boissiere, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., and Hirsch, E. C., Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience, 72, 355-363 (1996).
5. Lee, E., Choi, E. J., Cheong, H., Kim, Y. R., Ryu, S. Y., and Kim, K. M., Anti-allergic actions of the leaves of Castanea crenata and isolation of an active component responsible for the inhibition of mast cell degranulation. Arch. Pharm. Res., 22, 320-323 (1999).
6. McMurray, R. W., Bromocriptine in rheumatic and autoimmune diseases. Semin Arthritis Rheum., 31, 21-32 (2001).
7. Nozaki, H., Hozumi, K., Nishimura, T., and Habu, S., Regulation of NK activity by the administration of bromocriptine in haloperidol-treated mice. Brain Behav. Immun., 10, 17-26 (1996).
8. Oak, M. H., Cheong, H., and Kim, K. M., Activation of FceRI inhibits the pyruvate kinase through direct interaction with the gamma-chain. Int. Arch. Allergy Immunol., 119, 95-100 (1999).
9. Panajotova, V., The effect of dopaminergic agents on cell-mediated immune response in mice. Physiol. Res., 46, 113-118 (1997).
10. Ryu, S. Y., Oak, M. H., and Kim, K. M., Inhibition of mast cell degranulation by tanshinones from the roots of Salvia miltiorrhiza. Planta Med., 65, 654-655 (1999).
11. Sano, T., Uchida, M. K., and Suzuki-Nishimura, T., The effects of clozapine on rat mast cells are different from those of benzodiazepines. Gen. Pharmacol., 21, 559-561 (1990).
12. Schwartz, L. B., Austen, K. F., and Wasserman, S. I., Immunologic release of beta-hexosaminidase and beta-glucuronidase from purified rat serosal mast cells. J. Immunol., 123, 1445-1450 (1979).
13. Song, C., Lin, A., Kenis, G., Bosmans, E., and Maes, M., Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist. Schizophr. Res., 42, 157-164 (2000).